ThermoDiab

ThermoDiab is an intelligent system using a high-resolution infrared camera and Artificial Intelligence to detect diabetic foot complications

In development by MedVie, ThermoDiab received a Seal of Excellence from the European Commission in recognition of the standard of our recent SME Instrument Phase 1 funding application.

Diabetic foot disease is one of the most devastating, serious and costly complications of diabetes. Globally, there are over 422 million people living with diabetes, who have a 32% risk of developing a Diabetic Foot Ulceration (DFU) , which can be a precursor to further complications that may result in amputation. Diabetes-related amputation rates have increased year on year, but despite this, existing methods of identifying diabetic foot disease are outdated and unreliable which leads to diabetes foot disease not being recognised until irreversible damage to the health of the foot occurs.

Currently, there is a lack of a gold-standard technology on the market that allows for the early detection and prevention of DFUs. MedVie aims to address this challenge utilizing its extensive experience in diabetes research and medtech innovation to develop an effective and easy to use device that becomes the gold-standard solution leading to a substantial reduction in both the health expenditure and number of amputations related to Diabetic Foot Ulceration.

InDx Project

InDx is an EU funded Horizon 2020 project that seeks to develop an innovative orthopaedic implant that restores natural motion to patients with thumb base joint arthritis.

InDx is a two-year Fast Track to Innovation project that commenced in July 2019. MedVie assisted Loci Orthopaedics in drafting the successful grant proposal and are Project Managers of the resultant project. The Project Kick-off Meeting was held in Dublin on July 23rd 2019 attended by all four partners in the international project consortium.

The consortium is a group of innovative, world-leading, and complementary companies, who can significantly accelerate delivery of the InDx implant to market to meet a huge unmet clinical need. Loci Orthopaedics, EndoLab, and NAMSA have already started work on the performance testing and clinical trial plan required for EU regulatory approval. Medvie brings its strong expertise in medical device design, project management, and global commercialisation to the project and have initiated a commercialisation plan for the InDx implant.

.

InDx Project Partners

TESTIMONIALS

ATXA Therapeutics – Awarded SME Instrument Phase 2 Grant

“Cristina’s support was invaluable to ATXA Therapeutics Ltd during the preparation of our SME Instrument Phase II application. Her templates were excellent, ensuring coverage of all aspects and leaving no stone unturned. Her timely and rigorous advice during the review of our draft application was of enormous benefit to us, particularly in respect of challenging our overall business model, financial considerations and advising on revisions to the structure of the application. I feel certain that Cristina’s support was pivotal in us securing funding.

On behalf of ATXA Therapeutics Ltd, I offer the strongest possible sup- port to Cristina in recommending her to any other applicants when filing either a Phase I or Phase II SME Instrument application or indeed when filing any other type of proposal. Should the situation arise again for ATXA in making other types of applications, we will most certainly engage Cristina’s support.”

 

Dr. Therese Kinsella,

Founder & Chief Scientific Officer, ATXA Therapeutics.

Innopharma – Awarded SME Instrument Phase 2 Grant

“Cristina was required to take a lead role in all aspects of the scoping, drafting and final submission of our proposal. As an organisation we relied on her commercial experience as a senior product manager in industry and her knowledge of H2020 funding initiatives to direct us in formulating a strategy of the highest quality. We benefited greatly from Cristina’s project management abilities with respect to the clarity of purpose, momentum and organisational drive she injected into the strategic planning and application process and appreciate greatly the commitment Cristina made to ensuring our goals were met.”

Sean Costello,

Technical Operations Director, Innopharma.

“It was my pleasure to work with Cristina Purtill on a recent Horizon 2020 proposal. Cristina is very professional and calm and assured under pressure. She will pull out all stops to get the job done. She is technically very competent and a very good project manager with a hands-on approach to her work. I have no hesitation in recommending Cristina and look forward to working together in the future.”

Luke Kiernan,

Technology Director, Innopharma.

Serosep

“It has been a great pleasure to work with Cristina Purtill on our recent “Fast Track to Innovation” as part of the H2020 application process. We have felt that Cristina very quickly became part of Serosep’s team and this differentiates her from other consultants in the past. She did pull up her sleeves and did a lot of work and we delivered our application within a 2 week period. We remain very optimistic of our chances despite the significant competition.”

Dermot Scanlon,

CEO, Serosep.

Invizbox – Awarded SME Instrument Phase 1 Grant

“We recently sought the professional help of Cristina Purtill from SME Funding on a recent Horizon 2020 proposal. The experience was noth- ing short of excellent. Cristina’s professionalism and knowledge were extremely helpful. We found the one-on-one meetings and reviews along with the template proposals of massive benefit in getting us to the high standards needed to make a proposal. I have only great things to say about Cristina and will be delighted to work with her again in the future.”

Chris Monks,

CEO, Invizbox.

NEWS

MedVie move to new premises in Malahide, Dublin

1st September 2019

MedVie have moved to the Marine Court Centre, Malahide.
The new premises comes with inspiring views over Malahide marina included!

 

InDx Project Kick-Off Meeting

23rd July 2019

The InDx Project is an EU funded Horizon 2020 project that seeks to develop an innovative implant that restores natural motion to patients with thumb base joint arthritis. The project Kick-off Meeting was held in Dublin on July 23rd 2019 attended by representatives from each of the four partner organisations from across Europe. InDx Project coordinators, Loci Orthopaedics, and project managers MedVie, welcomed all participants and presented the project plan to achieve what will no doubt be a successful collaborative outcome.

MedVie receive Seal of Excellence for SME Instrument funding application

24th June 2019

MedVie’s application for SME Instrument Phase 1 funding for the ThermoDiab project “was scored as a high-quality project proposal in a highly competitive evaluation process” following evaluation by an international panel of independent experts. The Seal of Excellence means passing all stringet Horizon 2020 assessment thresholds for the three award criteria (Excellence, Impact, Quality and efficiency of implementation) required to receive funding from the EU budget Horizon 2020.

MedVie secure Horizon 2020 project funding with Loci Orthopaedics

15th December 2018

.

The InDx impant, developed by Loci Orthopaedics, is an innovative device that restores natural motion to patients with thumb base joint arthritis. MedVie and Loci Orthopaedics have secured EU “Fast Track to Innovation” H2020 funding to support a two year project to bring the InDx implant to market. The InDx consortium is a group of innovative, world-leading, and complementary companies, who can significantly accelerate the progression of the InDx implant to market and service a huge unmet clinical need.

BLOG

 

SME Instrument becomes EIC Accelerator

8th November 2019

On 6th June 2019, the EC website posted “The SME Instrument becomes the EIC Accelerator, offering optional equity investment in addition to a grant. From today, innovative companies can apply for a grant only or up to 17.5 million in combined grant and equity financing to scale-up quickly and effectively.

The grants available will be between € 0.5 and 2.5 million and equity investment can amount up to €15 million. The aim is to increase support for ground-breaking concepts that could shape new markets or disrupt existing ones in Europe and worldwide.”

CONTACT US


If you would like more information about MedVie services please send us an e-mail: info@medvie.ie

6 + 12 =

CONTACT DETAILS:

MedVie Ltd.
Marine Court Centre Malahide, Malahide, Co. Dublin,
Ireland.
K36 VK53

info@medvie.ie

Our Location

Share This